Logo image of SESN

SESEN BIO INC (SESN) Stock Fundamental Analysis

NASDAQ:SESN - Nasdaq - US8177631053 - Common Stock - Currency: USD

0.6288  +0.04 (+7.29%)

After market: 0.5832 -0.05 (-7.25%)

Fundamental Rating

3

Taking everything into account, SESN scores 3 out of 10 in our fundamental rating. SESN was compared to 571 industry peers in the Biotechnology industry. No worries on liquidiy or solvency for SESN as it has an excellent financial health rating, but there are worries on the profitability. SESN is valued expensive and it does not seem to be growing.


Dividend Valuation Growth Profitability Health

Quickly go to:

2

1. Profitability

1.1 Basic Checks

In the past year SESN has reported negative net income.
SESN had a positive operating cash flow in the past year.
SESN had negative earnings in each of the past 5 years.
In the past 5 years SESN always reported negative operating cash flow.
SESN Yearly Net Income VS EBIT VS OCF VS FCFSESN Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 0 20M -20M -40M -60M -80M -100M

1.2 Ratios

SESN has negative profitability rations, so we won't be analyzing them here.
SESN's Return On Invested Capital of 14.26% is amongst the best of the industry. SESN outperforms 97.33% of its industry peers.
Industry RankSector Rank
ROA N/A
ROE N/A
ROIC 14.26%
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
SESN Yearly ROA, ROE, ROICSESN Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 0 100 -100 200 300 400

1.3 Margins

SESN has a Operating Margin of 49.65%. This is amongst the best in the industry. SESN outperforms 98.90% of its industry peers.
In the last couple of years the Operating Margin of SESN has grown nicely.
SESN does not have Profit Margin and Gross Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM 49.65%
PM (TTM) N/A
GM N/A
OM growth 3YN/A
OM growth 5Y62.37%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
SESN Yearly Profit, Operating, Gross MarginsSESN Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 0 -2K -4K -6K

More info and screens

7

2. Health

2.1 Basic Checks

With a Return on Invested Capital (ROIC) just above the Cost of Capital (WACC), SESN is creating some value.
SESN has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
SESN Yearly Shares OutstandingSESN Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 50M 100M 150M
SESN Yearly Total Debt VS Total AssetsSESN Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 50M 100M 150M 200M

2.2 Solvency

SESN has an Altman-Z score of 1.65. This is a bad value and indicates that SESN is not financially healthy and even has some risk of bankruptcy.
The Altman-Z score of SESN (1.65) is better than 66.67% of its industry peers.
SESN has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0
Altman-Z 1.65
ROIC/WACC1.61
WACC8.88%
SESN Yearly LT Debt VS Equity VS FCFSESN Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 0 50M -50M 100M 150M

2.3 Liquidity

SESN has a Current Ratio of 5.54. This indicates that SESN is financially healthy and has no problem in meeting its short term obligations.
SESN has a Current ratio of 5.54. This is comparable to the rest of the industry: SESN outperforms 49.06% of its industry peers.
A Quick Ratio of 5.54 indicates that SESN has no problem at all paying its short term obligations.
SESN has a Quick ratio of 5.54. This is comparable to the rest of the industry: SESN outperforms 49.37% of its industry peers.
Industry RankSector Rank
Current Ratio 5.54
Quick Ratio 5.54
SESN Yearly Current Assets VS Current LiabilitesSESN Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 50M 100M 150M 200M

More info and screens

2

3. Growth

3.1 Past

SESN shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -364.00%.
SESN shows a strong growth in Revenue. In the last year, the Revenue has grown by 816.87%.
The Revenue has been decreasing by -2.41% on average over the past years.
EPS 1Y (TTM)-364%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%455.56%
Revenue 1Y (TTM)816.87%
Revenue growth 3YN/A
Revenue growth 5Y-2.41%
Sales Q2Q%N/A

3.2 Future

SESN is expected to show quite a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 12.42% yearly.
The Revenue is expected to decrease by -14.87% on average over the next years. This is quite bad
EPS Next Y-308%
EPS Next 2Y4.02%
EPS Next 3Y19.21%
EPS Next 5Y12.42%
Revenue Next Year-100%
Revenue Next 2Y-41.42%
Revenue Next 3Y-25.99%
Revenue Next 5Y-14.87%

3.3 Evolution

The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
SESN Yearly Revenue VS EstimatesSESN Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 5M 10M 15M 20M 25M
SESN Yearly EPS VS EstimatesSESN Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 -0.5 -1 -1.5 -2

More info and screens

2

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for SESN. In the last year negative earnings were reported.
Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for SESN. No positive earnings are expected for the next year.
Industry RankSector Rank
PE N/A
Fwd PE N/A
SESN Price Earnings VS Forward Price EarningsSESN Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 20 40 60 80

4.2 Price Multiples

SESN's Price/Free Cash Flow ratio is rather cheap when compared to the industry. SESN is cheaper than 97.96% of the companies in the same industry.
Industry RankSector Rank
P/FCF 13.31
EV/EBITDA -5.23
SESN Per share dataSESN EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 0.5 -0.5 -1

4.3 Compensation for Growth

SESN's earnings are expected to grow with 19.21% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y4.02%
EPS Next 3Y19.21%

More info and screens

0

5. Dividend

5.1 Amount

SESN does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

SESEN BIO INC

NASDAQ:SESN (3/7/2023, 7:50:19 PM)

After market: 0.5832 -0.05 (-7.25%)

0.6288

+0.04 (+7.29%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS IndustryBiotechnology
Earnings (Last)02-28 2023-02-28/bmo
Earnings (Next)05-08 2023-05-08
Inst OwnersN/A
Inst Owner ChangeN/A
Ins Owners1.16%
Ins Owner Change0%
Market Cap127.96M
Analysts43.33
Price Target12.24 (1846.56%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)100.94%
Min EPS beat(2)-20.66%
Max EPS beat(2)222.55%
EPS beat(4)3
Avg EPS beat(4)113.84%
Min EPS beat(4)-20.66%
Max EPS beat(4)222.55%
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)1900%
PT rev (3m)1900%
EPS NQ rev (1m)-1900%
EPS NQ rev (3m)-1900%
EPS NY rev (1m)0%
EPS NY rev (3m)0%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 2.13
P/FCF 13.31
P/OCF 13.31
P/B 0.78
P/tB 0.78
EV/EBITDA -5.23
EPS(TTM)-1.16
EYN/A
EPS(NY)-0.09
Fwd EYN/A
FCF(TTM)0.05
FCFY7.51%
OCF(TTM)0.05
OCFY7.51%
SpS0.29
BVpS0.81
TBVpS0.81
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA N/A
ROE N/A
ROCE N/A
ROIC 14.26%
ROICexc N/A
ROICexgc N/A
OM 49.65%
PM (TTM) N/A
GM N/A
FCFM N/A
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5Y62.22%
OM growth 3YN/A
OM growth 5Y62.37%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score4
Asset Turnover0.3
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0
Debt/EBITDA 0
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 5.54
Quick Ratio 5.54
Altman-Z 1.65
F-Score4
WACC8.88%
ROIC/WACC1.61
Cap/Depr(3y)25.56%
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-364%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%455.56%
EPS Next Y-308%
EPS Next 2Y4.02%
EPS Next 3Y19.21%
EPS Next 5Y12.42%
Revenue 1Y (TTM)816.87%
Revenue growth 3YN/A
Revenue growth 5Y-2.41%
Sales Q2Q%N/A
Revenue Next Year-100%
Revenue Next 2Y-41.42%
Revenue Next 3Y-25.99%
Revenue Next 5Y-14.87%
EBIT growth 1Y485.82%
EBIT growth 3YN/A
EBIT growth 5Y58.47%
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y126.61%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y126.61%
OCF growth 3YN/A
OCF growth 5YN/A